SCHEMBL2851274

SCHEMBL2851274

CC(=O)Nc1nc2ccc(Oc3cc(NC(=O)O)ccc3F)nc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.45
DYRK1A Q13627 8/20 0.44
PDPK1 O15530 1/20 0.44
ABL1 P00519 1/20 0.41
BCR P11274 1/20 0.41
FSCN1 Q16658 1/20 0.41
LDHA P00338 2/20 0.41
PDGFRB P09619 1/20 0.41
KIT P10721 1/20 0.41
FLT1 P17948 1/20 0.41
KDR P35968 1/20 0.41
RAB9A P51151 3/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862242 0.86 BRAF (0.47) BRAFDYRK1APDPK1FSCN1KDR
SCHEMBL2858259 0.85 CLK1 (0.51) BRAFDYRK1APDPK1FSCN1RAB9A
SCHEMBL2853481 0.84 EPHX2 (0.41) BRAFABL1BCRRAB9ASMN1; SMN2
SCHEMBL3512217 0.82 BRAF (0.46) BRAFDYRK1APDPK1FSCN1KDR
SCHEMBL2851409 0.82 BRAF (0.62) BRAFDYRK1APDPK1FSCN1PDGFRB
SCHEMBL2856446 0.81 DYRK1A (0.46) BRAFDYRK1APDPK1FSCN1RAB9A
SCHEMBL2856064 0.80 BRAF (0.44) BRAFDYRK1APDPK1FSCN1RAB9A
SCHEMBL14949669 0.79 BRAF (0.55) BRAFABL1BCRPDGFRBKIT
SCHEMBL2860133 0.78 KDR (0.55) BRAFDYRK1AABL1PDGFRBKIT
SCHEMBL2849273 0.77 KDR (0.53) BRAFPDGFRBKITFLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2184285-B1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2015-11-04 EP disclosed
EP-2247620-A1 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE Genentech, Inc. (US) 2010-11-10 EP disclosed
EP-2184285-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2010-05-12 EP disclosed
EP-2176296-A1 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE Genetech, Inc. (US) 2010-04-21 EP disclosed
WO-2009099728-A1 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE GENENTECH, INC. (US) 2009-08-13 WO disclosed
WO-2009012268-A1 ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE GENENTECH, INC. (US) 2009-01-22 WO disclosed